Urease and Helicobacter spp. Antigens in Pulmonary Granuloma

Journal of Comparative Pathology

Volumn 148, Issue 2-3, 2013, Pages 266-277

  Herndon, B ^a   Quinn, T ^a   Wasson, N ^a   Nzabi, M ^a   Molteni, A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Helicobacter spp.; Rat model; Sarcoidosis; Urease

Indexed keywords

INTERLEUKIN 1BETA; THROMBOCYTE ACTIVATING FACTOR; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; GASTROESOPHAGEAL REFLUX; HELICOBACTER; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; LUNG GRANULOMA; LUNG SARCOIDOSIS; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; FEMALE; GASTROESOPHAGEAL REFLUX; GRANULOMA; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1BETA; LUNG; LUNG DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SARCOIDOSIS, PULMONARY; UREASE;

ANIMALIA; HELICOBACTER; HELICOBACTER PYLORI; RATTUS;

EID: 84875263237     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2012.06.011     Document Type: Article

References (49)

1. Alvarez ML (1995) Spectroscopic and Magnetic Studies of Jack Bean Urease: pH and Buffer Effects on the Nickel (II) Coordination, PhD Thesis, Dartmouth College.
2. Antoniu S.A. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opinion in Therapeutic Targets 2010, 14:21-29.
3. Bauerfeind P., Garner R., Dunn B.E., Mobley H.L. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 1997, 40:25-30.
4. Baughman R.P., Culver D.A., Judson M.A. A concise review of pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine 2011, 183:573-581.
5. Baughman R.P., Lower E.E., Tami T. Upper airway 4: sarcoidosis of the upper respiratory tract. Thorax 2010, 65:181-186.
6. Baughman R.P., Nagai S., Balter M., Costabel U., Drent M., et al. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG task force. Sarcoidosis and Vascular Diffuse Lung Disease 2011, 28:56-64.
7. Bezuidenhout J (2005) An Investigation of Tuberculous Lung Tissue and a Comparison with Sarcoidosis, PhD Thesis, University of Stellenbosch Medical School.
8. Constantopoulos S.H. Ninth WASOG meeting and 11th BAL International Conference: something old, something new. Sarcoidosis and Vascular Diffuse Lung Disease 2008, 25:3-4.
9. Drake W.P. When a commensal becomes a pathogen. Sarcoidosis and Vascular Diffuse Lung Disease 2008, 25:10-11.
10. Follmer C., Real-Guerra R., Wasserman G.E., Olivera-Severo D., Carlini C.R. Jackbean, soybean and Bacillus pasteurii ureases: biological effects unrelated to ureolytic activity. European Journal of Biochemistry 2004, 271:1357-1363.
11. Gaia-Filho E.V., Goldenberg A., Costa H.O. Experimental model of gastroesophageal reflux in rats. Acta Cirurgica Brasileira 2005, 20:437-444.
12. Gencer M., Ceylan E., Yildiz-Zeyrak F., Aksoy N. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration 2007, 74:170-175.
13. Grissom C.K., Orme J.F., Richer L.D., McIntyre T.M., Zimmerman G.A., et al. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Critical Care Medicine 2003, 31:770-775.
14. Ha N.C., Oh S.T., Sung J.Y., Cha K.A., Lee M.H., et al. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nature Structural Biology 2001, 8:505-509.
15. Hellmig S., Titz A., Steinel S., Ott S., Folsch U.R., et al. Influence of IL-1 gene cluster polymorphisms on the development of H. pylori-associated gastric ulcer. Immunology Letters 2005, 100:107-112.
16. Herndon B, Langdon C (2005) B-cells in Th-1 Antigen-Induced Granuloma, Proceedings of the 8th Congress of the World Association of Sarcoidosis and other Granulomatous Disorders, p. 6.
17. Herndon B.L., Vlach V., Dew M., Willsie S.K. Helicobacter pylori-related immunoglobulins in sarcoidosis. Journal of Investigative Medicine 2004, 52:137-143.
18. Hutyrova B., Pantelidis P., Drabek J., Zurkova M., Kolek V., et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2002, 65:148-151.
19. Ilvan A., Ozturkeri H., Capraz F., Cermik H., Kunter E. Investigation of Helicobacter pylori in bronchoscopic lung specimens of young male patients with bronchiectasis but without gastrointestinal symptoms. Clinical Microbiology and Infection 2004, 10:257-260.
20. Kanbay M., Kanbay A., Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respiratory Medicine 2007, 101:203-209.
21. Kerr J.R., Al-Khattaf A., Barson A.J., Burnie J.P. An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection. Archives of Diseases of Childhood 2000, 83:429-434.
22. Langdon C., Herndon B. Immune recognition of urease: a source of pulmonary inflammation. American Journal of Respiratory and Critical Care Medicine 2004, 169:A813.
23. Majmudar P., Shaw S.M., Dhunjibhoy K.R., Desai H.G. Isolation of Helicobacter pylori from dental plaques in healthy volunteers. Indian Journal of Gastroenterology 1990, 9:271-272.
24. Mearin F., Ponce J., Ponce M., Balboa A., Gonzalez M.A., et al. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease. European Journal of Gastroenterology and Hepatology 2012, 24:665-674.
25. Megraud F., Neman-Simha V., Brugmann D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infection and Immunity 1992, 60:1858-1863.
26. Miyoshi S., Hamada H., Kadowaki T., Hamaguchi N., Ito R., et al. Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest 2010, 137:1391-1397.
27. Mobley H.L., Island M.D., Hausinger R.P. Molecular biology of microbial ureases. Microbiology and Molecular Biology Reviews 1995, 59:451-480.
28. Nguyen A.M., Engstrand L., Genta R.M., Graham D.Y., el-Zaatari F.A. Detection of Helicobacter pylori in dental plaque by reverse transcription polymerase chain reaction. Journal of Clinical Microbiology 1993, 31:873-877.
29. Notter R.H. Lung Surfactants: Basic Science and Clinical Applications 2000, Marcel Dekker, New York, p. 120.
30. Philippou N., Koursarakos P., Anastasakou E., Krietsepi V., Mavrea S., et al. Helicobacter pylori seroprevalence in patients with lung cancer. World Journal of Gastroenterology 2004, 10:3342-3344.
31. Radosz-Komoniewska H., Beck T., Jozwiak J., Martirosian G. Pathogenicity of Helicobacter pylori infection. Clinical Microbiology and Infection 2005, 11:602-610.
32. Raghunath A., Hungin A.P.S., Wooff D., Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. British Medical Journal 2003, 326:737-743.
33. Roussos A., Philippou N., Gourgoulianis K.I. Helicobacter pylori infection and respiratory diseases: a review. World Journal of Gastroenterology 2003, 9:5-8.
34. Roussos A., Philippou N., Mantzaris G.J., Gourgoulianis K.I. Respiratory diseases and Helicobacter pylori infection: is there a link?. Respiration 2006, 73:708-714.
35. Saltini C., Pallante M., Puxeddu E., Contini S., Voorter C.E., et al. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis and Vascular Diffuse Lung Disease 2008, 25:100-116.
36. Samet J.M., Cheng P.W. The role of airway mucus in pulmonary toxicology. Environmental Health Perspectives 1994, 102(Suppl. 2):89-103.
37. Sifrim D. Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut 2005, 54:175-178.
38. Sifrim D., Mittal R., Fass R., Smout A., Castell D., et al. Acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Alimentary Pharmacology and Therapeutics 2007, 25:1003-1015.
39. Slomiany B.L., Slomiany A. Platelet-activating factor mediates Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis. IUBMB Life 2004, 56:41-46.
40. Song Q., Lange T., Spahr A., Adler G., Bode G. Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. Journal of Medical Microbiology 2000, 49:349-353.
41. Straubinger R.K., Greiter A., McDonough S.P., Gerold A., Scanziani E., et al. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infection and Immunity 2003, 71:2693-2703.
42. Suzuki H., Miura S., Imaeda H., Suzuki M., Han J.Y., et al. Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers. Free Radical Biology and Medicine 1996, 20:449-454.
43. Svetlecic J., Molteni A., Herndon B. Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model. Lung 2004, 182:119-134.
44. Tsang K.W., Lam S.K., Lam W.K., Karlberg J., Wong B.C., et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1998, 158:1047-1051.
45. Tschumperlin D.J., Margulies S.S. Alveolar epithelial surface area-volume relationship in isolated rat lungs. Journal of Applied Physiology 1999, 86:2026-2033.
46. vanVliet A.H., Kuipers E.J., Waidner B., Davies B.J., deVries N., et al. Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcription level. Infection and Immunity 2001, 69:4891-4897.
47. Watson R.G.P., Tham T.C.K., Johnston B.T., McDougall N.I. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the 'sensitive oesophagus'. Gut 1997, 40:587-590.
48. Yahav J., Samra Z., Blau H., Dinari G., Chodick G., et al. Helicobacter pylori and Clostridium difficile in cystic fibrosis patients. Digestive Diseases and Sciences 2006, 51:2274-2279.
49. Yamanishi S., Iizumi T., Watanabe E., Shimizu M., Kamiya S., et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infection and Immunity 2006, 74:248-256.